In addition to its recurrent nature, we have demonstrated its high-copy number amplification, independence of MYC amplification, and uniqueness to medulloblastoma amongst a panel of >800 cell lines derived from different tumour types, indicating this novel amplicon contains key gene(s) in medulloblastoma development, with the potential to inform critical insights to disease pathogenesis. The gene discussed is MYC; the disease is medulloblastoma.